Skip to main content
Equibles
LXEO $3.07 +1.49%
LXEO logo
LXEO · Lexeo Therapeutics, Inc.
Track LXEO — free

Use LXEO with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research LXEO.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$3.07 +0.05 (+1.49%)
Russell 2000 member Rebalance outlook locked
Market Cap
$247.78M
Shares
82.05M
Volume · Oct 21 435.18K Avg daily vol (3M) 1.3M
All webcasts

Earnings call · FY2025 Q4

Lexeo Therapeutics, Inc. (LXEO) Q4 2025 Earnings Call

Concluded Jan 12, 2026
Jan 12, 2026 0 turns
Period
FY2025 Q4
Runtime
—
Sources
4 artifacts
Net income · derived Q4 -$20.96M
Open full screen Slides 32 8-K 8-K 10-K

Executive readout · one minute

Webcast research workspace

Read the call alongside every captured source. slides, 8-K earnings release, 8-K call announcement, 10-K stay in one workspace.

Research coverage

4 live sources

Open each available source without leaving this research workspace.

Research materials

Open the source you need; every reader stays inside this workspace.

Presentation 32 slides 8-K earnings release Filed Mar 30, 2026 8-K call announcement Filed Jan 12, 2026 10-K report Filed Mar 30, 2026 Company webcastOpen the original investor-relations page
Full-screen source Call document

LXEO alerts

Lexeo Therapeutics, Inc.

Create a free account or sign in to receive transcript alerts at your email address.

Continue to sign in
Read transcripts like this one from Claude, ChatGPT or your own code with the earnings call transcript API →